T1	Entity 65 72	19p13.1
T2	SNP 340 364	13 candidate causal SNPs
T3	Association 365 375	associated
E1	Association:T3 snp_int:T2 bc:T4 bc2:T5 bc3:T6
T4	Cancer 410 424	ER-negative BC
T5	Cancer 444 463	BRCA1-associated BC
T6	Cancer 486 504	triple negative BC
A1	Cancer_Type T6 TNBC_and_or_Basal_like
A2	Cancer_Type T4 ER-
A3	Cancer_Type T5 Molec_Status_other
T7	SNP 780 796	six risk alleles
R2	SNP_location Arg1:T7 Arg2:T1	
T8	Effect_Type 797 806	increased
T9	Gene_Regulation 807 822	transactivation
E2	Gene_Regulation:T9 Theme:T10 Agent:T7
T10	Entity 830 844	ADHD8 promoter
R3	Effect_type_marker Arg1:E2 Arg2:T8	
A4	Effect_Type E2 Increase
T11	SNP 896 906	rs56069439
T13	Entity 33 57	pleiotropic risk alleles
T14	Spec 912 920	putative
T15	Entity 921 929	enhancer
R6	Speculation_marker Arg1:T15 Arg2:T14	
R7	SNP_location Arg1:T11 Arg2:T15	
T17	Gene_Regulation 949 959	regulation
E3	Gene_Regulation:T17 Theme:T18 Theme2:T15 Agent:T11
A5	Effect_Type E3 Decrease
T18	Entity 938 944	ANKLE1
T16	Effect_Type 945 959	downregulation
R8	Effect_type_marker Arg1:E3 Arg2:T16	
T19	Other_effect 996 1014	functional effects
E4	Other_effect:T19 Agent:T21
T20	Entity 1022 1035	ANKLE1 3'-UTR
T21	SNP 1036 1039	SNP
R9	SNP_coupled_gene Arg1:T21 Arg2:T20	
T22	SNP 1077 1090	multiple SNPs
T23	Entity 1094 1099	19p13
R10	SNP_location Arg1:T22 Arg2:T23	
R11	SNP_location Arg1:T11 Arg2:T23	
T24	Association 1214 1218	risk
E5	Association:T24 bc:T25 snp_int:T22
T25	Cancer 1188 1194;1207 1213	breast cancer
T26	Gene_Regulation 1100 1108	regulate
E6	Gene_Regulation:T26 Theme:T27 Theme2:T29
T27	Entity 1109 1114	ABHD8
T28	Spec 1064 1071	suggest
R12	Speculation_marker Arg1:E6 Arg2:T28	
T29	Entity 1127 1133	ANKLE1
T30	SNP 33 57	pleiotropic risk alleles
R13	SNP_location Arg1:T30 Arg2:T1	
R14	Member Arg1:T30 Arg2:T2	
R15	Member Arg1:T30 Arg2:T11	
R16	Member Arg1:T30 Arg2:T22	
T31	Association 95 109	susceptibility
E7	Association:T31 bc:T32 snp_int:T30
T32	Cancer 73 79;88 94	breast cancer
